Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities (Q27345462)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities |
scientific article |
Statements
1 reference
Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities (English)
1 reference
1 reference
Kwok-Kin Wong
1 reference
Andrew Futreal
1 reference
Ignacio I Wistuba
1 reference
Carlo Toniatti
1 reference
John V Heymach
1 reference
Roy S Herbst
1 reference
Vassiliki A Papadimitrakopoulou
1 reference
Jianhua Zhang
1 reference
Gordon B Mills
1 reference
Ferdinandos Skoulidis
1 reference
Lauren A Byers
1 reference
Lixia Diao
1 reference
Pan Tong
1 reference
Julie Izzo
1 reference
Carmen Behrens
1 reference
Humam Kadara
1 reference
Edwin R Parra
1 reference
Jaime Rodriguez Canales
1 reference
Jianjun Zhang
1 reference
Uma Giri
1 reference
Jayanthi Gudikote
1 reference
Maria A Cortez
1 reference
Chao Yang
1 reference
Youhong Fan
1 reference
Michael Peyton
1 reference
Luc Girard
1 reference
Kevin R Coombes
1 reference
Timothy P Heffernan
1 reference
Murim Choi
1 reference
Vincent Miller
1 reference
John N Weinstein
1 reference
Padmanee Sharma
1 reference
Waun K Hong
1 reference
John D Minna
1 reference
Jing Wang
1 reference
11 June 2015
1 reference
1 reference
860-877
1 reference
Identifiers
1 reference
1 reference